Delayed myelination in a mouse model of fragile X syndrome.
about
Autism spectrum disorders and neuropathology of the cerebellumBehavioral and Neuroanatomical Phenotypes in Mouse Models of AutismAltered Translational Control of FMRP on Myelin Proteins in Neuropsychiatric DisordersWnt signaling networks in autism spectrum disorder and intellectual disabilityIn Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders.Reduced phenotypic severity following adeno-associated virus-mediated Fmr1 gene delivery in fragile X mice.Quantitative profiling of brain lipid raft proteome in a mouse model of fragile X syndromeGABAergic regulation of cerebellar NG2 cell development is altered in perinatal white matter injury.Specific effect of the fragile-X mental retardation-1 gene (FMR1) on white matter microstructure.Persistent astrocyte activation in the fragile X mouse cerebellumSex differences in neurodevelopmental and neurodegenerative disorders: Focus on microglial function and neuroinflammation during development.Impaired activity-dependent neural circuit assembly and refinement in autism spectrum disorder genetic models.Myocilin is involved in NgR1/Lingo-1-mediated oligodendrocyte differentiation and myelination of the optic nerve.Dysfunctional mTORC1 Signaling: A Convergent Mechanism between Syndromic and Nonsyndromic Forms of Autism Spectrum Disorder?The journey to autism: Insights from neuroimaging studies of infants and toddlers.Novel roles of amyloid-beta precursor protein metabolites in fragile X syndrome and autism.Drug discovery for remyelination and treatment of MS.Alterations in the Sp1 binding and Fmr-1 gene expression in the cortex of the brain during maturation and aging of mouse.The calcium-sensing receptor and integrins modulate cerebellar granule cell precursor differentiation and migration.Neuroanatomical Phenotypes Are Consistent With Autism-Like Behavioral Phenotypes in the 15q11-13 Duplication Mouse Model.An automated high-resolution in vivo screen in zebrafish to identify chemical regulators of myelination
P2860
Q26853603-20D2B9F4-C0BD-4E51-A936-BF129E6BA56EQ27025227-46CF2882-A889-44DF-A7F5-6BC00B85AB11Q28069747-7805BBB0-DA79-45C1-949E-21E0943DE50BQ28074740-327E5779-BC4C-4ADF-AEFD-E481E8667EC7Q31028468-C72395D5-00B3-4F4A-BE5F-2D8855DA0C9FQ34499370-D066703D-D0F6-431E-825A-4A8A8D4148F3Q35302189-EE8D473D-907A-4B5D-86FF-9F82D6D2BB0FQ35693647-FFDBA2E4-4619-456E-8AFD-77CBDE4E5764Q35913510-F63454AF-AEEE-417B-849E-3E6B8E1F9083Q36186534-09EF3188-AC7A-4916-B3E7-FEF00C63D7DCQ36792090-F1DE27D6-CD78-4087-8A17-6F7D70039C2DQ37564195-50439A6C-9314-44F7-BF36-FA01A7B3ABFEQ37705505-528BB128-4D8C-4D84-BF9D-0CD957DB98ACQ37729341-2513B132-A475-4033-881C-4A98E80968FFQ38557378-ABCD2B4C-EF6A-428D-8A6C-D2B90FAA71A8Q38826557-DB988B21-0631-4F9C-806B-3A8D71A51F48Q39375830-76170D10-6E24-49CC-8C7A-024173791C3FQ46613683-7E673652-8147-4502-A756-2C16B42869B0Q48097101-7D1FDDDB-8A6B-435F-AA40-CBBC3EF8E1EBQ48289037-E3973E39-688A-47F9-9706-A5FD5084B6B0Q56810654-665775FB-0485-4536-8A64-983B1E195D51
P2860
Delayed myelination in a mouse model of fragile X syndrome.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Delayed myelination in a mouse model of fragile X syndrome.
@en
Delayed myelination in a mouse model of fragile X syndrome.
@nl
type
label
Delayed myelination in a mouse model of fragile X syndrome.
@en
Delayed myelination in a mouse model of fragile X syndrome.
@nl
prefLabel
Delayed myelination in a mouse model of fragile X syndrome.
@en
Delayed myelination in a mouse model of fragile X syndrome.
@nl
P2093
P2860
P356
P1476
Delayed myelination in a mouse model of fragile X syndrome.
@en
P2093
Christian Thomsen
Dafna Sussman
David R Hampson
Ingrid C Y Xuan
Laura K K Pacey
R Mark Henkelman
Sihui Guan
P2860
P304
P356
10.1093/HMG/DDT246
P577
2013-06-04T00:00:00Z